LSLuiz Gustavo Guimarães Sacramento

Luiz Gustavo Guimarães Sacramento

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Luiz Gustavo Guimarães Sacramento has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Post-COVID cognitive dysfunction in socioeconomically-vulnerable older adults: findings from a Brazilian cohort

    by Danielle Calil de Sousa, Arnaldo Santos Leite, Luiz Gustavo Guimarães Sacramento, Bruna Achtschin Fernandes, Bárbara Caroline Dias Faria, Carolina Coimbra Marinho, Paulo Caramelli

    Cognitive impairment is increasingly recognized as a long-term consequence of coronavirus disease 2019 (COVID-19), but most evidence comes from high-income settings. Little is known about its impact in socioeconomically-vulnerable populations. The current study investigated long-term cognitive effects in 133 individuals older than 50 years of age with low level of schooling and low socioeconomic status who were hospitalized for COVID-19. The participants were assessed 12 to 18 months after hospitalization using the Modified Telephone Interview for Cognitive Status (TICS-M). A subset of 65 participants underwent further cognitive and neuropsychiatric evaluations. Cognitive impairment was defined as scores ≤ −1.5 standard deviations from age- and education-adjusted Brazilian norms. During the acute phase of the disease, sociodemographic, clinical, and laboratory data were evaluated to identify potential risk factors. The mean age of the subjects (n = 65) was of 65.3 years, and the sample was composed of 69.2% of women, 57.1% of pardo individuals, 47.7% of subjects with ≤ 4 years of schooling, and 83.6% of participants with monthly family income ≤ 3 minimum wages. Hospitalization averaged 16.1 days, and 55.4% required intensive care. Cognitive impairment affected 70.8% of the participants. Higher age, female sex, and hyposmia were associated with cognitive impairment. Cognitive impairment was frequent in this socioeconomically-vulnerable sample, a group still underrepresented in existing research.


  • Open Access

    The use of noninvasive measurements of intracranial pressure in patients with traumatic brain injury: a narrative review

    by Bárbara Caroline Dias Faria, Luiz Gustavo Guimarães Sacramento, André Vitor Rocha Queiroz, Fernanda de Andrade Dias Leite, Henrique Lacerda Lage Lopes de Oliveira, Thais Yuki Kimura, Rodrigo Moreira Faleiro

    Background The most frequent cause of death in neurosurgical patients is due to the increase in intracranial pressure (ICP); consequently, adequate monitoring of this parameter is extremely important. Objectives In this study, we aimed to analyze the accuracy of noninvasive measurement methods for intracranial hypertension (IH) in patients with traumatic brain injury (TBI). Methods The data were obtained from the PubMed database, using the following terms: intracranial pressure, noninvasive, monitoring, assessment, and measurement. The selected articles date from 1980 to 2021, all of which were observational studies or clinical trials, in English and specifying ICP measurement in TBI. At the end of the selection, 21 articles were included in this review. Results The optic nerve sheath diameter (ONSD), pupillometry, transcranial doppler (TCD), multimodal combination, brain compliance using ICP waveform (ICPW), HeadSense, and Visual flash evoked pressure (FVEP) were analyzed. Pupillometry was not found to correlate with ICP, while HeadSense monitor and the FVEP method appear to have good correlation, but sensitivity and specificity data are not available. The ONSD and TCD methods showed good-to-moderate accuracy on invasive ICP values and potential to detect IH in most studies. Furthermore, multimodal combination may reduce the error possibility related to each technique. Finally, ICPW showed good accuracy to ICP values, but this analysis included TBI and non-TBI patients in the same sample. Conclusions Noninvasive ICP monitoring methods may be used in the near future to guide TBI patients' management.


  • Open Access

    Use of modified Telephone Interview for Cognitive Status (TICS‐M) for cognitive impairment analysis one year after COVID‐19 hospitalization in Brazil

    by Luiz Gustavo Guimarães Sacramento, Danielle Calil Sousa, Arnaldo Santos Leite, Bruna Achtschin Fernandes, Paulo Caramelli, Carolina Coimbra Marinho

    Background: COVID‐19 infection primarily affects the respiratory system despite of short and medium‐term cognitive impairment has been increasingly reported. The Modified Telephone Interview for Cognitive Status (TICS‐M), validated for cognitive screening after stroke, assesses domains such as orientation, attention/calculation, language, and immediate and delayed episodic memory. Thus, the TICS‐M might be useful to remotely screen for cognitive impairment in individuals affected by COVID‐19.Method: Cross‐sectional multicenter study in Belo Horizonte, Brazil, with participants hospitalized with COVID‐19 confirmed by RT‐PCR or serology. All patients were aged 18+ years. Clinical and sociodemographic data were obtained through electronic medical records and/or interviews. Cognitive impairment screening was performed one year after hospital admission using the TICS‐M, with a cutoff point of 14 out of 39.Result: Ninety‐six patients were submitted to the test, of which 50 (52.1%) were women, 72 (75%) were self‐declared non‐white, 59 (64.15%) did not complete elementary school and the median age was 62 years (interquartile range 49‐69). There was no significant association between lower TICS‐M scores and sociodemographic data or previous medical history, except for higher educational level that appears to be a protective factor to lower scores on TICS‐M (OR 0.089, 95% CI:0,01‐0,7, p 0.008), which is demonstrated in Table 1. There was also no association between the scores and the clinical course during hospitalization as displayed in Table 2. Furthermore, length of hospital stay (p = 0.232) and length of stay in Intensive Care Unit (p = 0.565) did not impact the scores.Conclusion: In this study, 15% of the sample had cognitive impairment one year after hospitalization for COVID‐19 according to TICS‐M. The absence of an association between known risk factors for cognitive deficits and worse scores on the TICS‐M might have been influenced by the fact that only 13.5% of our sample did not have comorbidities. Lower education level was the only factor associated with worse scores, which indicates a possible need to adapt the test or the cutoff point for different educational levels.


  • Open Access

    An analysis of chronic kidney disease as a prognostic factor in pediatric cases of COVID-19

    by Bárbara Caroline Dias Faria, Luiz Gustavo Guimarães Sacramento, Carolina Sant’ Anna Filipin, Aniel Feitosa da Cruz, Sarah Naomi Nagata, Ana Cristina Simões e Silva

    Advanced age is a risk factor for severe infection by acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Children, however, often present with milder manifestations of Coronavirus Disease 2019 (COVID-19). Associations have been found between COVID-19 and multisystem inflammatory syndrome in children (MIS-C). Patients with the latter condition present more severe involvement. Adults with comorbidities such as chronic kidney disease (CKD) are more severely affected. This narrative review aimed to look into whether CKD contributed to more severe involvement in pediatric patients with COVID-19. The studies included in this review did not report severe cases or deaths, and indicated that pediatric patients with CKD and previously healthy children recovered quickly from infection. However, some patients with MIS-C required hospitalization in intensive care units and a few died, although it was not possible to correlate MIS-C and CKD. Conversely, adults with CKD reportedly had increased risk of severe infection by SARS-CoV-2 and higher death rates. The discrepancies seen between age groups may be due to immune system and renin-angiotensin system differences, with more pronounced expression of ACE2 in children. Immunosuppressant therapy has not been related with positive or negative effects in individuals with COVID-19, although current recommendations establish decreases in the dosage of some medications. To sum up with, CKD was not associated with more severe involvement in children diagnosed with COVID-19. Studies enrolling larger populations are still required.